SCHEMBL30228094

SCHEMBL30228094

CCOC(=O)N(C)c1ccc2c(-c3ccc(F)cc3Cl)cc(=O)oc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ HPGD P15428 4/20 0.45
▸ TDP1 Q9NUW8 4/20 0.45
▸ GLA P06280 3/20 0.45
▸ L3MBTL1 Q9Y468 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.41
▸ IGLV6-57 P01721 4/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ CASP1 P29466 3/20 0.41
▸ CASP7 P55210 3/20 0.41
▸ ATM Q13315 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30228101 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30228256 0.82 MEN1 (0.49) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30227967 0.81 ALDH1A1 (0.45) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30228331 0.79 MEN1 (0.43) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30228181 0.79 HPGD (0.63) ALDH1A1KDM4EHPGDTDP1L3MBTL1
SCHEMBL30762863 0.78 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDL3MBTL1CYP3A4
SCHEMBL20839167 0.78 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDL3MBTL1CYP3A4
SCHEMBL20847991 0.78 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDL3MBTL1CYP3A4
SCHEMBL30228195 0.78 MEN1 (0.42) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL30360979 0.78 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDL3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326732-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-10-23 — — US disclosed
WO-2023034346-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326732-A1 CHROMEN-2-ONE MODULATORS OF POLRMT POLRMT, TFAM, POLM ALDH1A1 3178/4885KDM4E 2158/4885MEN1 3371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback